Press Releases Search Search Category Topic Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Institute & Campus (3) Press release (78) (-) Science (9) Art (1) (-) Artificial Intelligence (4) Bacteria (1) Basic Research (2) BIH (2) BIMSB (3) Biochemistry & Proteomics (3) Campus (1) Campus Buch (1) (-) Cancer (5) Cardiovascular Research (7) Cell Biology (6) Charité (3) Clinical Research (1) Computational Biology (2) CRISPR/Cas9 (4) Data science (1) Developmental Biology (3) Diabetes (1) Disease-related Research (7) DZHK (3) ECRC (2) ERC (1) EU-Life (1) FMP (1) Gene Expression Regulation & RNA Biology (2) Genetics & Genomics (7) High-throughput technologies (1) History (1) Imaging (3) Immunology (4) Immunotherapy (2) LifeTime (4) MDC-Forschung (1) Metabolism (1) Multiple sclerosis (1) Muscular dystrophy (2) NAKO (1) Neuroscience (3) OpenScience (3) Organoids (4) Personalia (3) Postdocs (1) Research Highlights (12) Responsible Research (1) Signal Transduction (1) Single-cell analysis (11) Stem Cell Biology (7) Structural Biology & Biophysics (1) Systems Biology (4) Teachers & Pupils (1) Technology Platforms (1) Technology Transfer (1) Women in Science (1) Work and Family (1) 9 Results: Active Filter: ScienceArtificial IntelligenceCancer Sort: Result score Newest to oldest Oldest to newest Press Release No. 20 May 13, 2019 Berlin Why Hodgkin’s lymphoma cells grow uncontrollably Although classical Hodgkin’s lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery. A team at the MDC led by Professor Claus Scheidereit has now identified an important signaling molecule in the biology of this lymphoma: LTA. Press Release No. 19 May 06, 2019 Berlin 📺 Pan-European LifeTime Initiative is launching in Berlin More than 450 scientists, clinicians, patients, and stakeholders from 20 European countries have gathered in Berlin at the LifeTime Opening Conference. The pan-European initiative aims to revolutionize healthcare. Press Release No. 18 May 03, 2019 Berlin First “wave” of the German National Cohort is completed In late April, the Berlin-North study center at the MDC welcomed its 10,000th subject in the GNC health study. This completes the first round of baseline examinations. Press Release No. 16 April 26, 2019 Berlin Press Invitation: Opening Conference of LifeTime in Berlin The Opening Conference of LifeTime will take place on 6 and 7 May 2019 in Berlin. The pan-European research initiative aims to develop new technologies for the treatment and early detection of diseases. Press Release No. 32 December 21, 2018 Berlin Tracking development cell by cell is ‘Breakthrough of the Year’ – Berlin-based MDC is a hot spot for such research The U.S. journal Science has chosen single-cell analysis as the Breakthrough of the Year. A major international hot spot for the revolutionary technology is the Max Delbrück Center for Molecular Medicine (MDC) in Berlin. The European consortium LifeTime, which is coordinated from Berlin and Paris, intends to focus on this new approach. Press Release No. 6 March 21, 2018 Berlin LifeTime – a visionary proposal for an EU Flagship Reliably predicting the onset and trajectory of a disease might seem like a distant dream. But a European consortium is aiming to achieve exactly this using a set of emerging technologies with the analysis of single cells at their core. Press Release No. 34 December 20, 2017 Berlin The dark side of treating cancer with drugs What are the consequences if a cellular aging-like program is acutely activated in tumor cells? And what role does the stem cell program play in it? Press Release No. 5 January 25, 2016 Berlin Hacking the programs of cancer stem cells All of the cells in a tumor are the offspring of a single, aberrant cell, but they are not all alike. Only a few retain the capacity of the original cell to create an entire tumor. Such cancer stem cells can migrate to other tissues and become fatal metastases. To fully cure a patient’s cancer, it is crucial to find and eliminate all of these cells because any that escape can regenerate the tumor and trigger its spread through the body. Press Release No. 27 November 04, 2015 Berlin Uptake mechanisms of cytostatics discovered How does a cytostatic like cisplatin or carboplatin actually get into the cell? Scientists at the MaxDelbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and the Leibniz-Institut für Molekulare Pharmakologie (FMP) in Berlin, in cooperation with a Dutch group, have now succeeded in showing that the volume-regulated anion channel VRAC is 50 % responsible for active substance uptake. If one of the VRAC subunits LRRC8A or LRRC8D is down-regulated, cells take up considerably less of the anti-cancer drug. In addition to this finding, programmed cell death or apoptosis is also significantly disturbed when LRRC8A is missing. The researchers have thus identified a potential cause for therapy resistance.